LatestXi Jinping Arrives in Washington for First State Visit in Over a Decade
Health

From Rural New Mexico to FDA Leadership: Dr. Heidi Overton's Medical Journey

Margaret Manto
From Rural New Mexico to FDA Leadership: Dr. Heidi Overton's Medical Journey
Summary

Dr. Heidi Overton, Trump's nominee to lead the FDA, has risen from modest beginnings in rural New Mexico to become a prominent physician and healthcare leader. Her medical background and career trajectory demonstrate a commitment to serving underserved communities and advancing public health policy. As a potential FDA commissioner, Overton's appointment could significantly impact drug approval processes, pharmaceutical regulation, and healthcare accessibility across the United States. Understanding her professional experience and medical expertise is essential for patients and healthcare stakeholders evaluating her qualifications for this influential position.

Stat News

Originally published on

STAT News

By Margaret Manto

Read full article(opens in new tab)

Fetched: September 24, 2026 at 10:00 AM

More news you might be interested in

View all
Xi Jinping Arrives in Washington for First State Visit in Over a Decade
Health

Xi Jinping Arrives in Washington for First State Visit in Over a Decade

Chinese President Xi Jinping has arrived in Washington for his first state visit to the White House in over ten years, meeting with U.S. President Donald Trump to address escalating tensions between the two global superpowers. This diplomatic engagement represents a significant effort to improve bilateral relations and reduce geopolitical friction. The visit carries implications for international health cooperation, trade in pharmaceuticals and medical devices, and global public health initiatives that depend on U.S.-China collaboration. Both nations' ability to cooperate on healthcare challenges affects Puerto Rico's access to medications and medical innovations.

3 hours ago
NotiCel
Venezuela's Interim President Promises UN Elections Without Timeline
Health

Venezuela's Interim President Promises UN Elections Without Timeline

Venezuela's interim president Delcy Rodríguez announced before the 81st UN General Assembly that elections will be held in the country, though she provided no specific date. The statement comes following the capture of Nicolás Maduro and highlights the interim administration's diplomatic relations with the United States under President Donald Trump. This political development may have implications for healthcare access and medical services in Venezuela, a country facing significant public health challenges.

3 hours ago
NotiCel
Survey Reveals Travel Trends for Caribbean and Latin America in 2027: Mental Health Benefits
Health
AnxietyDepression

Survey Reveals Travel Trends for Caribbean and Latin America in 2027: Mental Health Benefits

A survey of frequent travelers from seven key Latin American and Caribbean markets reveals that 90% consider vacations a mental health investment, while 83% believe world-class experiences are available within the region. Marriott International's study highlights the growing recognition of travel's therapeutic value for psychological well-being. These findings underscore how leisure travel contributes significantly to stress reduction and overall mental wellness. The data suggests increasing interest in wellness-focused tourism throughout the Caribbean and Latin America through 2027.

3 hours ago
NotiCel
New Tool Helps Researchers Identify Flawed Clinical Trials Before They Mislead Evidence
Health
COVID-19

New Tool Helps Researchers Identify Flawed Clinical Trials Before They Mislead Evidence

Researchers have developed a new tool to detect problematic clinical trials—including those affected by human error or research misconduct—before they distort systematic reviews and influence treatment guidelines. Flawed studies can lead to inaccurate or harmful medical recommendations. A notable example occurred with ivermectin for COVID-19 treatment, where some trials used in systematic reviews were found to be inauthentic by U.S., U.K., and EU health authorities. Subsequent high-quality trials showed ivermectin provided little or no benefit. This new screening tool aims to strengthen the integrity of medical evidence and protect patients from potentially ineffective treatments.

3 hours ago
Medical Xpress